REATA PHARMACEUTICALS INC Quarterly Operating Lease, Payments in USD from Q1 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Reata Pharmaceuticals Inc quarterly/annual Operating Lease, Payments history and growth rate from Q1 2020 to Q1 2023.
  • Reata Pharmaceuticals Inc Operating Lease, Payments for the quarter ending March 31, 2023 was $3.9M, a 388% increase year-over-year.
  • Reata Pharmaceuticals Inc annual Operating Lease, Payments for 2022 was $9.5M, a 197% increase from 2021.
  • Reata Pharmaceuticals Inc annual Operating Lease, Payments for 2021 was $3.2M.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $3.9M +$3.1M +388% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q1 2022 $3.2M $800K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $3.2M $800K Oct 1, 2021 Dec 31, 2021 10-K 2022-02-28
Q3 2021 $800K +$100K +14.3% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $800K -$200K -20% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $800K -$100K -11.1% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-06
Q3 2020 $700K Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $1M Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $900K Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.